(Report ID: 27047) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,646 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 15 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 27047 | Apr, 3, 2005 | 73 | Female |
List of drugs the patient takes:
| Drug |
Effexor Xr |
Norvasc |
Synthroid |
Zestril |
Results from eHealthMe: 15 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Myoclonus | 1 (6.67%) |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Post Procedural Complication | 3 (75.00%) |
2 | Red Blood Cell Sedimentation Rate Decreased | 3 (75.00%) |
3 | Pathological Gambling | 1 (25.00%) |
4 | Suicidal Ideation | 1 (25.00%) |
5 | Obsessive-compulsive Personality Disorder | 1 (25.00%) |
6 | Emotional Distress | 1 (25.00%) |
7 | Urinary Incontinence | 1 (25.00%) |
8 | Depression | 1 (25.00%) |
9 | Hypersexuality | 1 (25.00%) |
3) Top co-used drugs drugs reported for the past 12 months:
| Name | Count |
1 | Toprol-xl | 4 |
2 | Plavix | 4 |
3 | Forteo | 3 |
4 | Allegra | 2 |
5 | Percocet | 2 |
6 | Paxil | 2 |
7 | Bumetanide | 2 |
8 | Viagra | 1 |
9 | Metronidazole | 1 |
10 | Flonase | 1 |
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Post Procedural Complication | 3 (20.00%) |
2 | Insomnia | 3 (20.00%) |
3 | Confusional State | 3 (20.00%) |
4 | Red Blood Cell Sedimentation Rate Decreased | 3 (20.00%) |
5 | Drug Withdrawal Syndrome | 2 (13.33%) |
6 | Atelectasis | 2 (13.33%) |
7 | Depression | 2 (13.33%) |
8 | Anxiety | 2 (13.33%) |
9 | Neuroleptic Malignant Syndrome | 2 (13.33%) |
10 | Mental Status Changes | 2 (13.33%) |
| Name | Count |
1 | Plavix | 7 |
2 | Ferrous Sulfate Tab | 6 |
3 | Neurontin | 6 |
4 | Zoloft | 6 |
5 | Oxycontin | 5 |
6 | Aspirin | 5 |
7 | Azathioprine | 4 |
8 | Valdecoxib | 4 |
9 | Lorazepam | 4 |
10 | Toprol-xl | 4 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
